We screened our high-yield retirement stocks, looking for quality companies that baby boomers can buy and hold forever. The ...

More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

On Wednesday, Goldman Sachs maintained a Buy rating on Pfizer Inc. (NYSE: NYSE:PFE) shares, while increasing the stock's price target to $33.00 from $32.00. The adjustment follows Pfizer's ...

On Wednesday, Goldman Sachs (NYSE:GS) maintained a Buy rating on Pfizer Inc. (NYSE: NYSE:PFE) shares, while increasing the stock's price target to $33.00 from $32.00. The adjustment follows Pfizer's ...

Prescription drugs like Paxlovid can help with COVID-19 symptoms, and Tamiflu can treat the flu. But these medications work best when taken soon after symptoms start, so it’s best to get tested ...

On Wednesday, Goldman Sachs maintained a Buy rating on Pfizer Inc ... primarily due to strong sales of its COVID-19 treatment, Paxlovid. Despite the positive financial results, Pfizer's shares ...

Demand for the drugmaker’s Paxlovid treatment spurred by the latest COVID wave and a U.S. national stockpile delivery led to $2.7 billion in sales for the drug, Pfizer said Tuesday. The company ...